
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) stock is trading higher on Wednesday after the company announced it entered into a $6 million securities purchase agreement with a private investor.
What To Know: NovaBay receives $3.85 million in the first closing of a $6 million deal with investor David E. Lazar, with a second $2.15 million closing contingent on stockholder approval at the 2025 annual meeting. Lazar is appointed CEO and joins the board as part of the agreement.